The University of British Columbia
Date of Award
11.21.2017
Program
Type 1 Diabetes, Prevent & Delay
Amount
$550,000
Term of Grant
48 months
Project Title
Engineering antigen-specific regulatory T cells for use in type 1 diabetes
Project Description
Funds support a work into a preclinical proof-of-principle for an engineered targeted Treg cell therapy to treat type 1 diabetes.